Print this page
Nearly two billion doses of COVID-19 vaccines have been secured for equitable distribution in 2021 to the 190 countries that have signed on to a World Health Organization-led partnership, according to a Friday announcement from the group.
Officials from the vaccine manufacturers said they expect delivery to begin in the first quarter of next year.
The partnership, known as COVAX, said the supply includes at least 1.3 billion doses for low- and middle-income countries.
With the first vaccine beginning to arrive in some high-income countries and a second nearing approval in the United States, the rest of the world has wondered when lifesaving treatment would reach them.
Print this page
While the first shots against COVID-19 are rolling out in the United States, Britain and Canada, nearly a quarter of the world s population likely will not have access to a vaccine until at least 2022, according to a new study.
Even in a best-case scenario, the world does not have the manufacturing capacity to cover the entire global population.
Wealthier countries made deals to buy the bulk of vaccine doses before the shots have even finished testing or received regulatory approval.
Meanwhile, a partnership aimed at securing vaccines for low- and middle-income countries has so far reserved only a fraction of the doses it has promised to deliver.
South Africa: Covid-19 - What Local Vaccine Production Actually Means allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.
Aspen Pharmacare will not produce Johnson & Johnson’s Covid-19 vaccine itself in South Africa. Instead, Aspen will be one of six sites globally responsible for putting the vaccine into vials and packing the jabs for distribution, Johnson & Johnson Chief Scientific Officer, Paul Stoffels, confirmed late on Tuesday.
Vaccines go through several different stages from the time they are formulated until they reach clinic shelves. The most complicated phases involve actually creating the vaccine solution. The last and final stage, in which prepared vaccines are filled into vials and packaged for delivery, is often called “fill and finish”.
No plant in South Africa has produced a vaccine itself in 25 years, Biovac Institute CEO, Dr Morena Makhoana says. Biovac is a public-private partnership created in 2003 to revive vaccine production in South Africa after the country stopped producing vaccines locally in the 1990s.
fire! fire! help. fire! will yare you all right, ma ? well, boys, it has been fun. with kate s help doc manages to get out of fort griffin alive. he heads north to dodge city, a well-known stop on the gambling circu circuit. dodge city s reputation as hell on the plains reaches all of the way to washington, d.c. where the press calls it a wicked town known to gamblers wrestlers,